Lucid Diagnostics (LUCD) announced that it has received written notification from the Listings Qualifications Department of the Nasdaq Stock Market that the company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD: